Innovative Ketamine Formulations: Enhancing Therapeutic Efficacy and Safety.

Summary

New delivery methods for ketamine show promise in reducing side effects while maintaining its powerful therapeutic benefits. Scientists have developed three key innovations: slow-release injections, molecular combinations, and dual-release formulas with aspirin. These advances help maintain steady drug levels in the body, potentially making treatments more effective and comfortable for patients dealing with depression and chronic pain.

Abstract

Ketamine, originally developed as an anesthetic, has shown significant potential for treating depression, chronic pain, and other conditions. However, its conventional formulations often result in side effects such as hallucinations and dizziness due to rapid spikes in blood concentration. This article explores recent patents that optimize ketamine delivery and efficacy: subcutaneous injectable compositions, ketamine conjugates with various molecules, and dual-release formulations combining ketamine with aspirin. These innovations promise to improve ketamine-based treatments' pharmacokinetic profiles, therapeutic outcomes, and safety.

Tags